MAPT and neuromuscular disease: In conclusion, the elevation of serum p-tau 181 and p-tau 217 in ALS subjects probably reflects the release of these species from denervated muscle fibres and point to the need for further studies on peripheral tau pathology in ALS and other neuromuscular diseases.